NSAID Use Profiles Derived from Reimbursement Data in France
Thérapie, 59 5 (2004) 541-546
Published online: 2007-03-01
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women
Manon Cairat, Marie Al Rahmoun, Marc J. Gunter, et al.Breast Cancer Research 22 (1) (2020)
https://doi.org/10.1186/s13058-020-01343-1
Pharmacoepidemiology of non-steroidal anti-inflammatory drugs
Nicholas Moore, Mai Duong, Sinem Ezgi Gulmez, Patrick Blin and Cecile DrozTherapies 74 (2) 271 (2019)
https://doi.org/10.1016/j.therap.2018.11.002
Does paracetamol still have a future in osteoarthritis?
Nicholas Moore, Francesco Salvo, Mai Duong and Sinem Ezgi GulmezThe Lancet 387 (10033) 2065 (2016)
https://doi.org/10.1016/S0140-6736(15)01170-8
Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC
Nicholas Moore, Francesco Salvo, Mai Duong, Patrick Blin and Antoine ParienteExpert Opinion on Drug Safety 13 (2) 167 (2014)
https://doi.org/10.1517/14740338.2014.846324
Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects
Martin WehlingEuropean Journal of Clinical Pharmacology 70 (10) 1159 (2014)
https://doi.org/10.1007/s00228-014-1734-6
Usage patterns of ‘over‐the‐counter’ vs. prescription‐strength nonsteroidal anti‐inflammatory drugs in France
Mai Duong, Francesco Salvo, Antoine Pariente, Abdelilah Abouelfath, Regis Lassalle, Cecile Droz, Patrick Blin and Nicholas MooreBritish Journal of Clinical Pharmacology 77 (5) 887 (2014)
https://doi.org/10.1111/bcp.12239
Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France
Nicholas Moore, Sinem Ezgi Gulmez, Dominique Larrey, Georges‐Philippe Pageaux, Séverine Lignot, Régis Lassalle, Jérémy Jové, Antoine Pariente, Patrick Blin, Jacques Bénichou and Bernard BégaudPharmacoepidemiology and Drug Safety 22 (2) 160 (2013)
https://doi.org/10.1002/pds.3371
Use of health insurance claim patterns to identify patients using nonsteroidal anti‐inflammatory drugs for rheumatoid arthritis
Marie‐Agnès Bernard, Jacques Bénichou, Patrick Blin, Alain Weill, Bernard Bégaud, Abdelilah Abouelfath, Nicholas Moore and Annie Fourrier‐RéglatPharmacoepidemiology and Drug Safety 21 (6) 573 (2012)
https://doi.org/10.1002/pds.3221
Validity of chronic drug exposure presumed from repeated patient interviews varied according to drug class
Pernelle Noize, Fabienne Bazin, Antoine Pariente, et al.Journal of Clinical Epidemiology 65 (10) 1061 (2012)
https://doi.org/10.1016/j.jclinepi.2012.04.009
Are traditional NSAIDs prescribed appropriately among French elderly with osteoarthritis? Results from the CADEUS cohort
Sinem Ezgi Gulmez, Cécile Droz-Perroteau, Régis Lassalle, et al.European Journal of Clinical Pharmacology 67 (8) 833 (2011)
https://doi.org/10.1007/s00228-011-1015-6
Terminologie utilisée concernant les bases de remboursement de l’assurance maladie en pharmaco-épidémiologie : une harmonisation nécessaire
Karin Martin-Latry and Audrey CougnardThérapie 65 (4) 379 (2010)
https://doi.org/10.2515/therapie/2010047
Pharmacoepidemiological research using French reimbursement databases: yes we can!
Karin Martin‐Latry and Bernard BégaudPharmacoepidemiology and Drug Safety 19 (3) 256 (2010)
https://doi.org/10.1002/pds.1912
Phytalgic®, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial
Alain Jacquet, Pierre-Olivier Girodet, Antoine Pariente, Karelle Forest, Laurent Mallet and Nicholas MooreArthritis Research & Therapy 11 (6) (2009)
https://doi.org/10.1186/ar2891
NSAIDs discontinuation and myocardial infarction
F. SALVO, A. PARIENTE, P. NOIZE, A. FOURRIER‐RÉGLAT and N. MOOREJournal of Thrombosis and Haemostasis 7 (9) 1600 (2009)
https://doi.org/10.1111/j.1538-7836.2009.03542.x
Ibuprofen: A Journey from Prescription to Over-the-Counter Use
Nicholas MooreJournal of the Royal Society of Medicine 100 (48_suppl) 2 (2007)
https://doi.org/10.1177/014107680710004801s01
Prescription du célécoxib (Célébrex®) lors de sa commercialisation : une étude conduite à partir de la base de données du régime général de l’assurance maladie de la région Aquitaine
Annie Fourrier-Réglat, Ségolène de Bailliencourt, Mathieu Molimard, et al.Therapies 60 (1) 25 (2005)
https://doi.org/10.2515/therapie:2005003